Description
Exogenus Therapeutics recognises that innovation, excellence, and competitiveness within companies are largely driven by the qualification and expertise of the human resources that are part of their structure.
In this context, the operation in aims to strengthen Exogenus Therapeutics’ capacity for innovation and competitiveness in developing and validating innovative therapeutic products based on extracellular vesicles obtained from sustainable and clinically relevant sources.
Through this reinforcement of its endogenous capacity, the company intends to accelerate the progression of therapeutic candidates to advanced stages, supported by robust production and quality control processes, evidence of safety and efficacy, and the creation of intellectual property.
